Longevity & AgingPress Release

Yale analysis shows which anti-aging strategies actually move biological age and which supplements fall flat

A Yale analysis of 51 studies found that certain drugs, healthy diets and exercise lowered DNA-based biological age, while popular supplements mostly did not.

Saturday, November 14, 2026 5 views
Published in ScienceDaily Aging
Article visualization: Yale analysis shows which anti-aging strategies actually move biological age and which supplements f

Summary

Yale researchers asked a practical question: which anti-aging strategies produce measurable changes in biological age? Their analysis of 51 studies, published in Nature Medicine, looked at how DNA-based blood tests known as epigenetic clocks respond to different interventions. Certain prescription medications, healthy diets and exercise measurably lowered biological age by these tests. The over-the-counter supplements included in the analysis generally showed little evidence of doing the same. The lead author, Raghav Sehgal, said this is the first time enough data has existed to show that these biomarkers respond consistently to some therapies. There is an important caveat, though. A lower score on an aging clock does not prove that a person will live longer or avoid diseases such as cancer, diabetes or dementia. Still, the work gives scientists a clearer way to compare anti-aging treatments, and it suggests that aging may be more flexible than once believed.

0:00--:--

Detailed Summary

Aging researchers have long lacked a clear answer to a basic question: which interventions actually change biological aging in a way we can measure? A team at Yale, working in the lab of Albert Higgins-Chen, set out to answer it, and the work matters because the market for anti-aging products far outpaces the evidence behind them.

The researchers analyzed 51 studies and examined how DNA-based blood tests, often called epigenetic clocks, shifted in response to different treatments. Their findings, published in Nature Medicine, indicate that certain prescription drugs, healthy diets and exercise can reduce biological age as these tests measure it. The popular over-the-counter supplements included in the analysis generally failed to produce meaningful reductions.

The lead author, Raghav Sehgal, noted that this had not been possible before because there was not enough data to show that these biomarkers respond consistently to interventions. He came to the field from computational cancer research, after his adviser suggested studying the aging process that underlies many diseases instead of tackling individual conditions one by one. The project drew on the entire Higgins-Chen laboratory.

For readers, the practical message is that the best-supported ways to move aging biomarkers are the ones with the strongest traditional health backing: regular exercise and a healthy diet, plus selected medications under medical guidance. Supplements marketed as anti-aging appear to deserve more skepticism, at least when judged by these particular clocks.

The caveats are significant. Changes in biological age markers do not necessarily mean people will live longer or avoid age-related disease. Epigenetic clocks are proxies, and the studies pooled may differ in population, duration and design. Readers should treat the results as evidence about biomarker responsiveness, not proof of lifespan extension, and consult the Nature Medicine paper for the specific drugs, diets and supplements involved.

Key Findings

  • Yale analyzed 51 studies of anti-aging interventions measured with DNA-based biological age tests.
  • Certain prescription drugs, healthy diets and exercise measurably reduced biological age.
  • Popular over-the-counter anti-aging supplements generally showed little evidence of lowering biological age.
  • Lower biological age scores do not prove longer life or protection from age-related diseases.
  • Results show aging biomarkers respond consistently to some therapies, aiding future evaluation of treatments.

Methodology

This is a university-sourced news report on a Nature Medicine analysis of 51 studies. The source is credible, but the article is a summary and gives few details on study designs or specific interventions. Evidence rests on changes in DNA-based biomarkers, not clinical outcomes.

Study Limitations

The article does not name the specific drugs, diets or supplements, or the size of the effects, so check the Nature Medicine paper. Epigenetic clocks are surrogate markers, and the researchers stress that changes may not translate into longer life or less disease. Pooled studies may vary in quality, duration and participants.

Enjoyed this summary?

Get the latest longevity research delivered to your inbox every week.

Enter your email to subscribe: